---
aliases: >-
  /news/kelonia-therapeutics-emerges-with-50m-to-deliver-precision-targeted-genetic-medicines
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic
    Medicines
categories:
  - 'Symplur: Precision Medicine'
  - 'Symplur: Genomics'
categorySlug:
  - 'symplur: precision medicine'
  - 'symplur: genomics'
categoryUrl:
  - topic/symplur-precision-medicine
  - topic/symplur-genomics
categoryLabel:
  - Precision Medicine
  - Genomics
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2022-05-02'
description: >-
  Kelonia Therapeutics focused on vivo gene delivery, launched with a $50M in
  funding to expand the benefit and reach of genetic medicines.What You Should
  Know:– Kelonia Therapeutics, a Boston-based bio
favIconImage: null
featuredImage:
  alt: >-
    Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic
    Medicines
  format: JPEG
  href: 2ad17d14-49c3-5b7b-b46b-6200e4155881-featuredImage.jpeg
  size:
    - 919
    - 894
  valid: true
  workPackage: 12806
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/23811/content
featuredPdf: null
htmlMetaData:
  author: null
  description: null
  generator: null
  viewport: null
  articlemodified_time: null
  articlepublished_time: null
  msvalidate.01: null
  ogdescription: >-
    Kelonia Therapeutics focused on vivo gene delivery, launched with a $50M in
    funding to expand the benefit and reach of genetic medicines.
  ogimage: null
  ogsite_name: null
  ogtitle: >-
    Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic
    Medicines
  ogtype: null
  ogupdated_time: null
  ogurl: null
  yandex-verification: null
  robots: null
  fbapp_id: null
  oglocale: null
  fbadmins: null
  articlepublisher: null
  google-site-verification: null
  keywords: null
id: 12806
identifier: News
lastMod: '2022-05-02T11:08:37.424372Z'
link:
  brand: hitconsultant.net
  href: 'https://hitconsultant.net/2022/05/02/kelonia-therapeutics-genetic-medicines/'
  original: 'https://hitconsultant.net/2022/05/02/kelonia-therapeutics-genetic-medicines/'
href: 'https://hitconsultant.net/2022/05/02/kelonia-therapeutics-genetic-medicines/'
original: 'https://hitconsultant.net/2022/05/02/kelonia-therapeutics-genetic-medicines/'
mastHead: NEWS
mdName: 2ad17d14-49c3-5b7b-b46b-6200e4155881.md
openGraphMetaData:
  ogdescription: >-
    Kelonia Therapeutics focused on vivo gene delivery, launched with a $50M in
    funding to expand the benefit and reach of genetic medicines.
  ogtitle: >-
    Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic
    Medicines
  ogurl: null
  ogimage: null
  ogsite_name: null
  ogtype: null
  ogupdated_time: null
  ogimageheight: null
openProjectCustomFields:
  cleanUrl: 'https://hitconsultant.net/2022/05/02/kelonia-therapeutics-genetic-medicines/'
  medigyTopics:
    - 'Symplur: Precision Medicine'
    - 'Symplur: Genomics'
  sourceUrl: 'https://hitconsultant.net/2022/05/02/kelonia-therapeutics-genetic-medicines/'
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  hitconsultant-kelonia-therapeutics-emerges-with-50m-to-deliver-precision-targeted-genetic-medicines
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic
  Medicines
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: Amadeus
    permalink: /offering/amadeus
    categories:
      - 'Symplur: Precision Medicine'
    offeringId: 9466
twitterMetaData:
  twittercard: null
  twitterdescription: >-
    Kelonia Therapeutics focused on vivo gene delivery, launched with a $50M in
    funding to expand the benefit and reach of genetic medicines.
  twittertitle: >-
    Kelonia Therapeutics Emerges with $50M to Deliver Precision Targeted Genetic
    Medicines
  twitterimage: null
  twitterurl: null
---
<p>Kelonia Therapeutics focused on vivo gene delivery, launched with a $50M in funding to expand the benefit and reach of genetic medicines.<br><br><strong>What You Should Know:</strong></p><p>– <a href="https://keloniatx.com/">Kelonia Therapeutics</a>, a Boston-based biotech company focused on vivo gene delivery, launched with a $50 million in Series A funding to expand the benefit and reach of genetic medicines.</p><p>– Despite life-changing responses, existing gene therapies are highly complex, costly, and limited by complicated treatment paradigms, tractable therapeutic applications, and dose-limiting toxicities. By enabling precisely targeted, highly efficient, manufacturable “off-the-shelf” in vivo gene delivery, Kelonia’s technology has the potential to dramatically expand the impact and reach of genetic medicines to every patient in need.</p>